Galapagos has appointed David R. Smith as CFO beginning February 1, 2006. He joins Galapagos from AstraZeneca, where he was Marketing Company CFO.
Arrow International named Kenneth E. Imler as senior vice president of regulatory affairs and quality assurance. Before joining Arrow, Imler served as a principal consultant for Quintiles Consulting.
Novo Nordisk has appointed Christopher Porter as director of government affairs in the US. Prior to joining Novo Nordisk, Porter was the original co-staff director of the Congressional Diabetes Caucus.
Emilio A. Emini, Ph.D., was appointed executive vice president, vaccines research and development, Wyeth Pharmaceuticals. Emini joins Wyeth from the International AIDS Vaccine Initiative, where he was senior vice president for vaccine development.
Metabolon announced the addition of Dr. Michael Milburn as its chief scientific officer. Milburn was most recently senior vice president of research and corporate development at Sirtris Pharmaceuticals.
Arnold A. Pinkston has joined Beckman Coulter as senior vice president, general counsel and secretary. Previously, Pinkston was with Eli Lilly and served as deputy general counsel with responsibilities for the legal affairs of Lilly USA.
MDS has appointed Kenneth Horton As executive vice president, corporate development and general counsel. Horton joins MDS from PerkinElmer, where he held the role of vice president, acquisitions, ventures and general counsel for the Life and Analytical Sciences business unit.
Pozen has named Dr. Elly Savaluny vice president of biostatistics and data management.
Amarin announces appointment of Tom Maher as general counsel. Maher is currently a partner and head of the Life Sciences Group at Matheson Ormsby Prentice.
Sangamo BioSciences has appointed Dr. Philip Gregory as vice president of research. Dr. Gregory has served as Sangamo's senior director, research since July 2003.
CardioGenesis announced the addition of Gary S. Allen, M.D., to its board of directors.
Myrtle Potter, former Genentech president, has been appointed to the board of directors of FoxHollow Technologies.
Global Alliance for TB Drug Development has appointed Mark Kessel to its board of directors.
Friend G. Choate has been named to Escalon Medical's board of directors.